Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility

Marcela de Souza1, Tetsuhiro Matsuzawa2, Luzia Lyra3

  • 1Department of Internal Medicine, School of Medicine, University of Campinas, Campinas, São Paulo Brazil ; LIM 46 - Laboratory of Parasitology - HC/FMUSP, Kragujevac, São Paulo Brazil.

Springerplus
|September 12, 2014
PubMed
Abstract

Insights

Disseminated fusariosis caused by Fusarium napiforme is rare, particularly in immunocompromised patients. This case highlights the need for rapid diagnostics and effective antifungal treatments for invasive Fusarium infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Case Study

Background:

  • Fusarium species are increasingly recognized as significant pathogens in humans, especially immunocompromised individuals.
  • Invasive, life-threatening infections caused by Fusarium spp. pose a considerable risk.
  • Commonly implicated species include Fusarium solani, Fusarium oxysporum, and Fusarium verticillioides.

Purpose of the Study:

  • To report the second documented case of disseminated fusariosis caused by Fusarium napiforme.
  • To detail the clinical presentation and diagnostic findings in a patient with multiple myeloma undergoing chemotherapy.
  • To evaluate the antifungal susceptibility profile of the isolated Fusarium napiforme.

Main Methods:

  • Morphological identification (macroscopic and microscopic) of Fusarium napiforme.
  • Molecular methods, including sequencing, for definitive species identification.
  • Antifungal susceptibility testing against seven antifungal drugs.

Main Results:

  • The patient, a 60-year-old woman with multiple myeloma, developed disseminated fusariosis after chemotherapy.
  • Fusarium napiforme was identified using both traditional and molecular techniques.
  • Azoles demonstrated the highest in vitro activity against the F. napiforme isolates.

Conclusions:

  • Fusarium species are clinically relevant fungal pathogens.
  • The observed low susceptibility to certain antifungal drugs underscores the need for improved diagnostic methods.
  • Faster and more accurate diagnostics are crucial for timely and effective treatment of invasive fusariosis.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...